REMISSION OF TYPE 2 DIABETES (T2DM) IN 33.6% (51 OF 152) HYPOGONADAL MEN RECEIVING LONG-TERM TESTOSTERONE THERAPY FOR UP TO 12 YEARS IN A REAL-LIFE REGISTRY STUDY

被引：0

作者：

Haider, K. S. ^{[1
]}

Haider, A. ^{[1
]}

机构：

[1] Praxis Dr Haider, Bremerhaven, Germany

来源：

JOURNAL OF SEXUAL MEDICINE | 2020年 / 17卷 / 01期

关键词：

D O I：

10.1016/j.jsxm.2019.11.220

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

375

引用

页码：S104 / S104

页数：1

共 50 条

[1] Remission of Type 2 Diabetes (T2DM) in 33.6% (51 of 152) Hypogonadal Men Receiving Long-Term Testosterone Therapy for Up to 12 Years in a Real-Life Registry Study
Haider, Karim S.
Haider, Ahmad
Saad, Farid
DIABETES, 2019, 68
[2] Remission of Type 2 Diabetes in 12% (16 of 133) Hypogonadal Men Receiving Long-Term Testosterone Therapy in a Real-Life Registry Study
Haider, Ahmad
Haider, Karim S.
Saad, Farid
DIABETES, 2018, 67
[3] IMPROVEMENT OF TYPE 2 DIABETES (T2DM) IN HYPOGONADAL MEN RECEIVING LONG-TERM TESTOSTERONE THERAPY: REAL-LIFE EVIDENCE FROM A 10-REGISTRY STUDY IN A UROLOGICAL OFFICE
Saad, F.
Haider, K.
Haider, A.
JOURNAL OF SEXUAL MEDICINE, 2018, 15 (02): : S21 - S22
[4] Sustained Improvement of Obesity in Hypogonadal Men with Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU)-Real-Life Evidence from a Urological Registry Study
Saad, Farid
Haider, Karim S.
Haider, Ahmad
DIABETES, 2018, 67
[5] Long-Term Testosterone Therapy Results in Remission of Type 2 Diabetes (T2DM) in 34.3% (61 of 178) Men with Hypogonadism and T2DM in a Real-World Registry Study
Haider, Karim S.
Haider, Ahmad
Saad, Farid
DIABETES, 2020, 69
[6] LONG-TERM EFFECTS ON ERECTILE FUNCTION UPON TREATMENT UP TO 11 YEARS WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) IN HYPOGONADAL MEN WITH TYPE 2 DIABETES MELLITUS (T2DM): REAL-LIFE DATA FROM AN OBSERVATIONAL REGISTRY STUDY
Yassin, Aksam
Al Mehmadi, Yousef
JOURNAL OF UROLOGY, 2015, 193 (04): : E904 - E904
[7] TESTOSTERONE TREATMENT LEADS TO SUSTAINED IMPROVEMENTS OF ERECTILE FUNCTION UP TO 11 YEARS IN HYPOGONADAL MEN WITH TYPE 2 DIABETES MELLITUS (T2DM): REAL-LIFE DATA FROM AN OBSERVATIONAL REGISTRY STUDY
Saad, F.
Yassin, A.
JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 403 - 403
[8] Sustainable Weight Loss in hypogonadal Men with Type 2 Diabetes (T2 DM) under Long-Term Treatment with Testosterone: Real-life Experience from a urological Registry Study
Saad, Farid
Haider, Ahmad
Haider, Karim Sultan
Doros, Gheorghe
Traish, Abdulmaged
WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 351 - 352
[9] Improvement of Type 2 Diabetes (T2DM) and Reduction of Major Adverse Cardiovascular Events and Mortality in Hypogonadal Men Receiving Long-Term Treatment with Injectable Testosterone Undecanoate ( TU)-Real-Life Evidence from a Urological Registry Study
Saad, Farid
Haider, Karim S.
Haider, Ahmad
DIABETES, 2018, 67
[10] No progression from prediabetes to type 2 diabetes in 45 hypogonadal men receiving testosterone therapy (TTh) for up to 9 years: real-life data from a registry study
Haider, A.
Haider, K. S.
Doros, G.
Saad, F.
DIABETOLOGIA, 2017, 60 : S395 - S395

← 1 2 3 4 5 →